US 12,295,909 B2
Adapter for use in a planetary mixer
Panagiota Danopoulos, St-Laurent (CA)
Assigned to MEDISCA PHARMACEUTIQUE INC, Saint-Laurent (CA)
Filed by MEDISCA PHARMACEUTIQUE INC., St-Laurent (CA)
Filed on Nov. 3, 2023, as Appl. No. 18/501,446.
Application 18/501,446 is a continuation of application No. 17/123,442, filed on Dec. 16, 2020, granted, now 11,883,359.
Application 17/123,442 is a continuation of application No. 16/372,006, filed on Apr. 1, 2019, granted, now 10,993,876, issued on May 4, 2021.
Application 16/372,006 is a continuation of application No. 16/131,986, filed on Sep. 14, 2018, granted, now 10,420,705, issued on Sep. 24, 2019.
Application 16/131,986 is a continuation of application No. 15/809,636, filed on Nov. 10, 2017, granted, now 10,231,903, issued on Mar. 19, 2019.
Claims priority of provisional application 62/420,426, filed on Nov. 10, 2016.
Prior Publication US 2024/0108543 A1, Apr. 4, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61J 3/04 (2006.01); A61J 1/05 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/107 (2006.01); A61K 31/045 (2006.01); A61K 31/135 (2006.01); A61K 31/137 (2006.01); A61K 31/192 (2006.01); A61K 31/195 (2006.01); A61K 31/196 (2006.01); A61K 31/197 (2006.01); A61K 31/351 (2006.01); A61K 31/4418 (2006.01); A61K 31/4422 (2006.01); A61K 31/445 (2006.01); A61K 31/4458 (2006.01); A61K 31/565 (2006.01); A61K 31/57 (2006.01); A61K 31/7048 (2006.01); A61K 33/14 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/38 (2006.01); A61K 47/42 (2017.01); A61K 47/46 (2006.01); B01F 29/00 (2022.01); B01F 29/10 (2022.01); B01F 29/32 (2022.01); B01F 31/00 (2022.01); B01F 35/22 (2022.01); B01F 35/42 (2022.01); B29B 7/10 (2006.01); B65B 7/16 (2006.01)
CPC A61J 1/05 (2013.01) [A61J 3/04 (2013.01); A61K 9/0034 (2013.01); A61K 9/06 (2013.01); A61K 9/107 (2013.01); A61K 31/045 (2013.01); A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/192 (2013.01); A61K 31/195 (2013.01); A61K 31/196 (2013.01); A61K 31/197 (2013.01); A61K 31/351 (2013.01); A61K 31/4418 (2013.01); A61K 31/4422 (2013.01); A61K 31/445 (2013.01); A61K 31/4458 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01); A61K 31/7048 (2013.01); A61K 33/14 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01); A61K 47/42 (2013.01); A61K 47/46 (2013.01); B01F 29/10 (2022.01); B01F 29/32 (2022.01); B01F 29/40 (2022.01); B01F 29/4011 (2022.01); B01F 29/40221 (2022.01); B01F 31/00 (2022.01); B01F 35/2209 (2022.01); B01F 35/421 (2022.01); B29B 7/106 (2013.01); B65B 7/16 (2013.01); B01F 29/40365 (2022.01)] 29 Claims
 
1. A method of preparing a composition comprising:
creating a pharmaceutical composition in a bladeless planetary mixer,
wherein the composition is held within a container and includes a gelatin-based material; and
mixing the composition in the bladeless planetary mixer using superimposed revolution and rotation movements performed on the container using determined parameters to increase the temperature of the gelatin-based material to at least 50.5° C. and not greater than 72.8° C. to melt the gelatin-based material.